Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women

Published:1992-01 Issue:8784 Volume:339 Page:
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

EARLYBREASTCANCERTRIALISTSCOL

Publisher

Elsevier BV

Subject

General Medicine

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential risk of tamoxifen: gut microbiota and inflammation in mice with breast cancer;Frontiers in Oncology;2023-07-04

2. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival;BMC Cancer;2023-05-19

3. The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness;Frontiers in Endocrinology;2023-02-23

4. Ischemic stroke as the first manifestation of anthracycline cardiomyopathy;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2022-11-13

5. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients;Clinical and Translational Radiation Oncology;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP